Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer

11 Sept 2018

Abstract excerpt

Predicting response to systemic treatments in breast cancer (BC) patients is an urgent, yet still unattained health aim. Easily detectable molecules such as long non-coding RNAs (lncRNAs) are the ideal biomarkers when they act as master regulators of many resistance mechanisms, or of mechanisms that are common to more than one treatment. These kinds of markers are pivotal in quasi-personalized treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related molecular mechanisms research
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30208633
DOI: 10.3390/ijms19092711

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast CancerPMID 30208633Read ↗

Long Noncoding RNAs in Taxane Resistance of Breast CancerSemantic proximity Read ↗

Roles of long noncoding RNA in triple‐negative breast cancerSemantic proximity Read ↗

The Role of Drug Resistance Causing lncRNAs in Breast Cancer: In-silico AnalysisSemantic proximity Read ↗

Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectivesSemantic proximity Read ↗

Transcriptomic insights into the development and therapy of breast cancer via the ncRNA-mediated ceRNA regulation networkSemantic proximity Read ↗

The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast CancerSemantic proximity Read ↗

Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a reviewSemantic proximity Read ↗

Breast cancer lncRNA-microRNA categories: new targets for therapeutic interventionSemantic proximity Read ↗

Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical ApplicationsSemantic proximity Read ↗

Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancerSemantic proximity Read ↗

Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancerSemantic proximity Read ↗

A Novel Group of Genes that Causes Endocrine Resistance in Breast Cancer Identified by Dynamic Gene Expression AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.